Menstrual cycle and oral contraceptive use do not modify postexercise heat loss responses

2008 ◽  
Vol 105 (4) ◽  
pp. 1156-1165 ◽  
Author(s):  
Glen P. Kenny ◽  
Emily Leclair ◽  
Ronald J. Sigal ◽  
W. Shane Journeay ◽  
Donald Kilby ◽  
...  

It is unknown whether menstrual cycle or oral contraceptive (OC) use influences nonthermal control of postexercise heat loss responses. We evaluated the effect of menstrual cycle and OC use on the activation of heat loss responses during a passive heating protocol performed pre- and postexercise. Women without OC ( n = 8) underwent pre- and postexercise passive heating during the early follicular phase (FP) and midluteal phase (LP). Women with OC ( n = 8) underwent testing during the active pill consumption (high exogenous hormone phase, HH) and placebo (low exogenous hormone phase, LH) weeks. After a 60-min habituation at 26°C, subjects donned a liquid conditioned suit. Mean skin temperature was clamped at ∼32.5°C for ∼15 min and then gradually increased, and the absolute esophageal temperature at which the onset of forearm vasodilation (Thvd) and upper back sweating (Thsw) were noted. Subjects then cycled for 30 min at 75% V̇o2 peak followed by a 15-min seated recovery. A second passive heating was then performed to establish postexercise values for Thvd and Thsw. Between 2 and 15 min postexercise, mean arterial pressure (MAP) remained significantly below baseline ( P < 0.05) by 10 ± 1 and 11 ± 1 mmHg for the FP/LH and LP/HH, respectively. MAP was not different between cycle phases. During LP/HH, Thvd was 0.16 ± 0.24°C greater than FP/LH preexercise ( P = 0.020) and 0.15 ± 0.23°C greater than FP/LH postexercise ( P = 0.017). During LP/HH, Thsw was 0.17 ± 0.23°C greater than FP/LH preexercise ( P = 0.016) and 0.18 ± 0.16°C greater than FP/LH postexercise ( P = 0.001). Postexercise thresholds were significantly greater ( P ≤ 0.001) than preexercise during both FP/LH (Thvd, 0.22 ± 0.03°C; Thsw, 0.13 ± 0.03°C) and LP/HH (Thvd, 0.21 ± 0.03°C; Thsw, 0.14 ± 0.03°C); however, the effect of exercise was similar between LP/HH and FP/LH. No effect of OC use was observed. We conclude that neither menstrual cycle nor OC use modifies the magnitude of the postexercise elevation in Thvd and Thsw.

2019 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Laura Barba-Moreno ◽  
Rocío Cupeiro ◽  
Nuria Romero-Parra ◽  
Xanne A.K. Janse de Jonge ◽  
Ana B. Peinado

1995 ◽  
Vol 39 (3) ◽  
pp. 197-200 ◽  
Author(s):  
Ullacarin Wreje ◽  
Per Kristiansson ◽  
Hans Åberg ◽  
Birgitta Byström ◽  
Bo von Schoultz

2005 ◽  
Vol 288 (1) ◽  
pp. H103-H110 ◽  
Author(s):  
Jessica R. Meendering ◽  
Britta N. Torgrimson ◽  
Belinda L. Houghton ◽  
John R. Halliwill ◽  
Christopher T. Minson

Numerous studies have shown that the female sex hormones estrogen and progesterone have multiple effects on the vasculature. Thus our goal was to investigate the effects of estrogen and progesterone on calf venous compliance by looking for cyclic changes during the early follicular, ovulatory, and midluteal phases of the menstrual cycle and during high and low hormone phases of oral contraceptive use. Additionally, we wanted to compare the venous compliance of normally menstruating women, oral contraceptive users, and men. We studied eight normally menstruating women (23 ± 1 yr of age) during the early follicular, ovulatory, and midluteal phases of the menstrual cycle. Nine triphasic oral contraceptive users (21 ± 1 yr of age) were studied during weeks of high and low hormone concentrations. Eight men (23 ± 1 yr of age) were studied twice within 2–4 wk. With the use of venous occlusion plethysmography with mercury in-Silastic strain gauges, lower limb venous compliance was measured by inflating a venous collection cuff that was placed on the thigh to 60 mmHg for 8 min and then reducing the pressure to 0 mmHg at a rate of 1 mmHg/s. Venous compliance was calculated as the derivative of the pressure-volume curves. There were no differences between early follicular, ovulatory, and midluteal phases of the menstrual cycle or between high and low hormone phases of oral contraceptive use ( P > 0.05). Male venous compliance was significantly greater than in normally menstruating women ( P < 0.001) and oral contraceptive users ( P < 0.002). These data support a sex difference but also suggest that venous compliance does not change with menstrual cycle phase or during the course of oral contraceptive use.


Bone ◽  
2021 ◽  
Vol 145 ◽  
pp. 115864
Author(s):  
Dan Martin ◽  
Simon B. Cooper ◽  
Jonathan C.Y. Tang ◽  
William D. Fraser ◽  
Craig Sale ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document